PYY(3-36) induces Fos in the arcuate nucleus and in both catecholaminergic and non-catecholaminergic neurons in the nucleus tractus solitarius of rats

Peptides

Volumn 29, Issue 1, 2008, Pages 112-119

  Blevins, J E ^a,b   Chelikani, P K ^c   Haver, A C ^d   Reidelberger, R D ^c,d  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d VA NEBRASKA WESTERN IOWA HEALTH CARE SYSTEM   (United States)

Author keywords

Forebrain; Fos; Hindbrain; PYY(3 36); Satiety; Tyrosine hydroxylase

Indexed keywords

PEPTIDE YY; PROTEIN FOS; TYROSINE 3 MONOOXYGENASE;

AMYGDALOID NUCLEUS; ANIMAL CELL; ANIMAL TISSUE; ANTERIOR HYPOTHALAMUS; ARCUATE NUCLEUS; AREA POSTREMA; ARTICLE; BRAIN NERVE CELL; CATECHOLAMINE NERVE CELL; CATECHOLAMINE SYNTHESIS; CELL ACTIVATION; CONTROLLED STUDY; FOOD INTAKE; FOREBRAIN; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RHOMBENCEPHALON; SENSORY NERVE; SOLITARY TRACT NUCLEUS; VAGUS NERVE; ZONA INCERTA;

ANIMALS; ARCUATE NUCLEUS; CATECHOLAMINES; EATING; IMMUNOHISTOCHEMISTRY; INFUSIONS, INTRAVENOUS; MALE; NEURONS; PEPTIDE YY; PROTO-ONCOGENE PROTEINS C-FOS; RATS; RATS, SPRAGUE-DAWLEY; SOLITARY NUCLEUS; TYROSINE 3-MONOOXYGENASE;

PRIMATES; RATTUS; RODENTIA;

EID: 37449018122     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.peptides.2007.11.003     Document Type: Article

References (39)

1. Abbott C.R., Monteiro M., Small C.J., Sajedi A., Smith K.L., Parkinson J.R., et al. The inhibitory effects of peripheral administration of peptide YY(3-36) and glucagon-like peptide-1 on food intake are attenuated by ablation of the vagal-brainstem-hypothalamic pathway. Brain Res 1044 (2005) 127-131
2. Alessi N.E., Quinlan P., and Khachaturian H. MSG effects on beta-endorphin and alpha-MSH in the hypothalamus and caudal medulla. Peptides 9 (1988) 689-695
3. Amblard M., Fehrentz J.A., Martinez J., and Subra G. Methods and protocols of modern solid phase peptide synthesis. Mol Biotechnol 33 (2006) 239-254
4. Batterham R.L., Cohen M.A., Ellis S.M., Le Roux C.W., Withers D.J., Frost G.S., et al. Inhibition of food intake in obese subjects by peptide YY3-36. N Engl J Med 349 (2003) 941-948
5. Batterham R.L., Cowley M.A., Small C.J., Herzog H., Cohen M.A., Dakin C.L., et al. Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418 (2002) 650-654
6. Berglund M.M., Hipskind P.A., and Gehlert D.R. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes. Exp Biol Med (Maywood) 228 (2003) 217-244
7. Blevins J.E., Eakin T.J., Murphy J.A., Schwartz M.W., and Baskin D.G. Oxytocin innervation of caudal brainstem nuclei activated by cholecystokinin. Brain Res 993 (2003) 30-41
8. Bonaz B., Taylor I., and Tache Y. Peripheral peptide YY induces c-fos-like immunoreactivity in the rat brain. Neurosci Lett 163 (1993) 77-80
9. Challis B.G., Pinnock S.B., Coll A.P., Carter R.N., Dickson S.L., and O'Rahilly S. Acute effects of PYY3-36 on food intake and hypothalamic neuropeptide expression in the mouse. Biochem Biophys Res Commun 311 (2003) 915-919
10. Chelikani P.K., Haver A.C., Reeve Jr. J.R., Keire D.A., and Reidelberger R.D. Daily, intermittent intravenous infusion of peptide YY(3-36) reduces daily food intake and adiposity in rats. Am J Physiol Regul Integr Comp Physiol 290 (2006) R298-R305
11. Chelikani P.K., Haver A.C., and Reidelberger R.D. Intravenous infusion of peptide YY(3-36) potently inhibits food intake in rats. Endocrinology 146 (2005) 879-888
12. Chen Z., Eriste E., Jonsson A.P., Norberg A., Nepomuceno D., Lovenberg T.W., et al. Ser(13)-phosphorylated PYY from porcine intestine with a potent biological activity. FEBS Lett 492 (2001) 119-122
13. Date Y., Shimbara T., Koda S., Toshinai K., Ida T., Murakami N., et al. Peripheral ghrelin transmits orexigenic signals through the noradrenergic pathway from the hindbrain to the hypothalamus. Cell Metab 4 (2006) 323-331
14. Degen L., Oesch S., Casanova M., Graf S., Ketterer S., Drewe J., et al. Effect of peptide YY3-36 on food intake in humans. Gastroenterology 129 (2005) 1430-1436
15. Eberlein G.A., Eysselein V.E., Schaeffer M., Layer P., Grandt D., Goebell H., et al. A new molecular form of PYY: structural characterization of human PYY(3-36) and PYY(1-36). Peptides 10 (1989) 797-803
16. Fetissov S.O., Byrne L.C., Hassani H., Ernfors P., and Hokfelt T. Characterization of neuropeptide Y Y2 and Y5 receptor expression in the mouse hypothalamus. J Comp Neurol 470 (2004) 256-265
17. Fraser K.A., Raizada E., and Davison J.S. Oral-pharyngeal-esophageal and gastric cues contribute to meal-induced c-fos expression. Am J Physiol Regul Integr Comp Physiol 268 (1995) R223-R230
18. Grandt D., Schimiczek M., Beglinger C., Layer P., Goebell H., Eysselein V.E., et al. Two molecular forms of peptide YY (PYY) are abundant in human blood: characterization of a radioimmunoassay recognizing PYY1-36 and PYY3-36. Regul Pept 51 (1994) 151-159
19. Halatchev I.G., and Cone R.D. Peripheral administration of PYY(3-36) produces conditioned taste aversion in mice. Cell Metab 1 (2005) 159-168
20. Halatchev I.G., Ellacott K.L., Fan W., and Cone R.D. Peptide YY3-36 inhibits food intake in mice through a melanocortin-4 receptor-independent mechanism. Endocrinology 145 (2004) 2585-2590
21. Koda S., Date Y., Murakami N., Shimbara T., Hanada T., Toshinai K., et al. The role of the vagal nerve in peripheral PYY3-36-induced feeding reduction in rats. Endocrinology 146 (2005) 2369-2375
22. Koegler F.H., Enriori P.J., Billes S.K., Takahashi D.L., Martin M.S., Clark R.L., et al. Peptide YY(3-36) inhibits morning, but not evening, food intake and decreases body weight in rhesus macaques. Diabetes 54 (2005) 3198-3204
23. le Roux C.W., Batterham R.L., Aylwin S.J., Patterson M., Borg C.M., Wynne K.J., et al. Attenuated peptide YY release in obese subjects is associated with reduced satiety. Endocrinology 147 (2006) 3-8
24. Moran T.H., Smedh U., Kinzig K.P., Scott K.A., Knipp S., and Ladenheim E.E. Peptide YY(3-36) inhibits gastric emptying and produces acute reductions in food intake in rhesus monkeys. Am J Physiol Regul Integr Comp Physiol 288 (2005) R384-R388
25. Nonaka N., Shioda S., Niehoff M.L., and Banks W.A. Characterization of blood-brain barrier permeability to PYY3-36 in the mouse. J Pharmacol Exp Ther 306 (2003) 948-953
26. Olson B.R., Freilino M., Hoffman G.E., Stricker E.M., Sved A.F., and Verbalis J.G. c-Fos expression in rat brain and brainstem nuclei in response to treatments that alter food intake and gastric motility. Mol Cell Neurosci 4 (1993) 93-106
27. Palkovits M., Mezey E., and Eskay R.L. Pro-opiomelanocortin-derived peptides (ACTH/beta-endorphin/alpha-MSH) in brainstem baroreceptor areas of the rat. Brain Res 436 (1987) 323-338
28. Parker R.M., and Herzog H. Regional distribution of Y-receptor subtype mRNAs in rat brain. Eur J Neurosci 11 (1999) 1431-1448
29. Paxinos G., Carrive P., Wang H., and Wang P.-Y. Chemo architectonic atlas of the rat brainstem (1999), Academic Press, Orlando
30. Rinaman L. Hindbrain noradrenergic lesions attenuate anorexia and alter central cFos expression in rats after gastric viscerosensory stimulation. J Neurosci 23 (2003) 10084-10092
31. Rinaman L., Verbalis J.G., Stricker E.M., and Hoffman G.E. Distribution and neurochemical phenotypes of caudal medullary neurons activated to express cFos following peripheral administration of cholecystokinin. J Comp Neurol 338 (1993) 475-490
32. Shapiro R.E., and Miselis R.R. The central organization of the vagus nerve innervating the stomach of the rat. J Comp Neurol 238 (1985) 473-488
33. Shaw J.L., Gackenheimer S.L., and Gehlert D.R. Functional autoradiography of neuropeptide Y Y1 and Y2 receptor subtypes in rat brain using agonist stimulated [35S]GTPgammaS binding. J Chem Neuroanat 26 (2003) 179-193
34. Sloth B., Holst J.J., Flint A., Gregersen N.T., and Astrup A. Effects of PYY1-36 and PYY3-36 on appetite, energy intake, energy expenditure, glucose and fat metabolism in obese and lean subjects. Am J Physiol Endocrinol Metab 292 (2007) E1062-E1068
35. Talsania T., Anini Y., Siu S., Drucker D.J., and Brubaker P.L. Peripheral exendin-4 and peptide YY(3-36) synergistically reduce food intake through different mechanisms in mice. Endocrinology 146 (2005) 3748-3756
36. Tschop M., Castaneda T.R., Joost H.G., Thone-Reineke C., Ortmann S., Klaus S., et al. Physiology: does gut hormone PYY3-36 decrease food intake in rodents?. Nature 430 (2004) 165-166
37. Weeks J.R. Long-term intravenous infusion. In: Myers R.D. (Ed). Methods in psychobiology (1972), Academic Press, London 155-168
38. Willing A.E., and Berthoud H.R. Gastric distension-induced c-fos expression in catecholaminergic neurons of rat dorsal vagal complex. Am J Physiol Regul Integr Comp Physiol 272 (1997) R59-R67
39. Zheng H., Patterson L.M., Phifer C.B., and Berthoud H.R. Brain stem melanocortinergic modulation of meal size and identification of hypothalamic POMC projections. Am J Physiol Regul Integr Comp Physiol 289 (2005) R247-R258